Chronic Arsenic-Exposed Human Prostate Epithelial Cells Exhibit Stable Arsenic Tolerance: Mechanistic Implications of Altered Cellular Glutathione and Glutathione S-transferase

• Published in: Toxicology and applied pharmacology Vol. 183; no. 2; pp. 99 - 107
• Main Authors: Brambila, Eduardo M., Achanzar, William E., Qu, Wei, Webber, Mukta M., Waalkes, Michael P.
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.09.2002; Elsevier
• Subjects: Adaptation, Physiological; Arsenic - pharmacology; arsenic resistance; Base Sequence; Biological and medical sciences; Chemical and industrial products toxicology. Toxic occupational diseases; DNA Primers; Epithelial Cells - drug effects; Epithelial Cells - enzymology; Epithelial Cells - metabolism; Glutathione - metabolism; Glutathione Transferase - metabolism; human; Humans; Male; Medical sciences; Metals and various inorganic compounds; prostate; Prostate - cytology; Prostate - drug effects; Prostate - enzymology; Prostate - metabolism; Reverse Transcriptase Polymerase Chain Reaction; Toxicology; human; arsenic resistance; prostate; Human; Chronic; Arsenic; Toxicity; Tolerance; Epithelial cell; Mechanism of action; In vitro; Prostate; Adaptation; Glutathione; Heavy metal
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1006/taap.2002.9468

Acquisition of stable arsenic tolerance in human cells following chronic arsenic exposure has not been previously reported. In the present work, we describe acquisition of stable arsenic tolerance in the human prostate epithelial cell line RWPE-1 following chronic arsenic exposure in vitro. RWPE-1 cells continuously exposed to 5 μM sodium arsenite for ≥18 weeks exhibited dramatic resistance to acute arsenite toxicity. The LC50 for acute arsenite exposure in these chronic arsenic-exposed prostate epithelial (CAsE-PE) cells was 43.8 μM versus 17.6 μM in control cells. Similar results were obtained using the antineoplastic agent arsenic trioxide. This tolerance was stable, as CAsE-PE cells grown in arsenic-free medium for 5 weeks retained their resistant phenotype. Compared to control cells, CAsE-PE cells showed a 90% reduction in arsenic accumulation over 24 h coupled with a 2.6-fold increase in the rate of arsenic efflux. CAsE-PE cells had increased basal GSH levels (4.9-fold) and increased GST activity (2.4-fold) and both GSH depletion and inhibition of GST activity abolished arsenic tolerance. Arsenic tolerance was also abolished by treatment with inhibitors of the Mdr1 and Mrp1 transporters, although no increases in mdr1 or mrp1 gene expression were observed. Our results indicate that this tolerance in human cells involves increases in GSH levels and GST activity that allow for more efficient arsenic efflux by MRP1 and MDR1. This study represents the first report of stable acquired arsenic tolerance in human cells, which could have important implications for both the toxicology and the pharmacology of arsenic.